Ketone esters for the treatment of seizures in AS – clinical trial coming soon!
Medical foods as an effective approach to management of Angelman Syndrome The following is a recount of a presentation about using therapeutic ketones (KES)
Medical foods as an effective approach to management of Angelman Syndrome The following is a recount of a presentation about using therapeutic ketones (KES)
Read our regular series summarizing lectures presented on Friday December 4th, 2015, the first day of the 2015 FAST Global Summit. This series will be focuse
Read about the recently published paper «Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome
Agilis Biotherapeutics, LLC Drs. Greg Robinson and Jodi Cook This is gene therapy. A virus (adeno-associated virus=AAV) is used to carry (vector) the UBE
The Development Of OV101 As A Potential Treatment For The Symptoms Of Angelman Syndrome Ovid Therapeutics: Ovid therapeutics is currently assessing the deve
*Disclaimer: All of the summaries published here are only an interpretation by A. Berent of each lecture. None of these lectures were personally transcribed
Watch all the presentations from the 2015 Science Summit in Chicago
Please join us in welcoming Allyson Berent to the position of Science Director on the Foundation for Angelman Syndrome Therapeutics (FAST) Board of Dire
«Genomic imprinting affects the manner in which mutations in UBE3A produce symptoms of Angelman Syndrome» says FIRE team member and Associate Professor Dr.
Is it possible to “turn on” or express the UBE3A gene? Dr. David Segal from the University of California Davis talks about the FIRE funded project his la